 "Vice-President M Venkaiah Naidu")
Bharat Biotech's top brass on Friday called on Vice President M Venkaiah Naidu in Hyderabad.
"The discussion revolved around the status of the indigenous vaccine and the plans to make it available in India and rest of the world. It is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV)," an official statement said.
The indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment facility, the statement said.
Recently, Prime Minister Narendra Modi had visited Bharat Biotech's facility and reviewed the status of Covaxin. It was followed by a visit of 70 ambassadors and high commissioners from several nations to the facility at Genome Valley, Hyderabad, it said.
During the interaction, the vice president stressed on the importance of public-private partnership in coming out with indigenous world-class products and lauded the collaboration between the ICMR and Bharat Biotech, it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
